Market Capitalization

Epson challenges display giants with its first dvLED line, leveraging advanced COB tech and a simplified design in a bold move beyond its projector legacy.

Amazon's historic rise to No. 1 on the Fortune 500 signals a definitive power shift, crowning the digital economy over traditional American business.

A recent FDA approval for a generic cancer drug adds to a growing market, revealing the strategic alliances redefining healthcare access.

As demand for solar surges, a new report reveals alarming failure rates in PV modules, forcing a high-stakes reckoning over long-term performance and profit.

While others debate AI's future, CEO Eric Vaughan brings a radical playbook of M&A and cultural overhaul to the main stage, proving enterprise AI is here.

As The Conference Board honors S&P Global and UL Solutions, it’s clear that investing in people is no longer a soft skill—it's the core of modern strategy.

The brand sold out its new high-protein frozen dessert in under 30 minutes. Here's the strategy, technology, and market forces behind the viral launch.

Largest shareholder Al Shams Investments demands a shareholder meeting, alleging Braemar's board is captive to its advisor amid a high-stakes strategic review.

Stonegate Capital's updated coverage validates AB Science's pivot to ALS and AML, but can its promising clinical assets and shrewd financing de-risk the path forward?

NexTel Medical acquires two telehealth firms for an instant $135K in monthly revenue, aiming to launch its Maxasome™ exosome therapies to 1,850 clinics.

As ad dollars flood Connected TV, marketers grapple with a chaotic sea of fragmented data. A new AI platform, Kortex, promises a unified map to ROI.

A generational shift is underway as Millennials and Gen Z flock to the pre-owned luxury watch market, armed with data and viewing timepieces as tangible investments.

A landmark Canada-South Korea deal for LNG, crude, and critical minerals offers a new blueprint for de-risking supply chains and creates major opportunities for investors.

The $320B tokenized asset market is notoriously illiquid. Symbiotic's Liquid Lane aims to change that with a novel shared collateral model for instant redemptions.

As the Pentagon plans a 200,000-drone fleet, one small firm is making a big play. Mobilicom's pitch to top investors reveals a critical new frontline: cybersecurity.

With real estate worth more than its stock and ambitious R&D plans, Cosmos Health claims it's undervalued. But is an unusual crypto strategy clouding the picture?

With a $1.25 billion investment from Apollo Funds, McKesson is spinning off its medical supply unit. Is this a cure for corporate bloat or a new symptom of financialization in healthcare?

QuadReal's appointment of Deloitte veteran Trevor Nakka signals a strategic pivot, adding elite financial governance to its $98.5B portfolio to fuel a disciplined global expansion.

Neil Jesani Advisors' high-profile board appointments reveal a new playbook for growth, where political savvy and tech innovation are the ultimate currency.

Browser innovator Shift renews its $25K Impact Grant, fueling sustainable startups as the tech industry grapples with its growing environmental footprint.